| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

( McArdle Memorial Laboratory, The Medical School, University of Wisconsin, Madison 6, Wis.)
Seventeen drugs which demonstrated in vitro inhibitory activity against an oxidative system for the conversion of orotic acid to the uridine nucleotides were retested against a nonoxidative system. The 5-bromo, 5-chloro and 5-fluoro analogs of orotic acid were demonstrated to produce single or multiple blocking actions against this system.
* This work was supported in part by a grant (No. C2409) from the National Cancer Institute, National Institutes of Health, United States Public Health Service.
Present address: General Medical Research, Veterans Administration Research Hospital, 333 East Huron Street, Chicago 11, Ill.
Received 4/29/57.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |